[1]CurrentPatentAssignee:GLENMARKPHARMACEUTICALSLTD-WO2016/55934,2016,A1Locationinpatent:Paragraph0129
[2]CurrentPatentAssignee:NANJINGHUAWEMEDICALTECHNOLOGYDEVELOPMENTCO.,LTD.-CN105523994,2016,ALocationinpatent:Paragraph0048;0049;0050
[3]CurrentPatentAssignee:NANJINGHUAWEMEDICALTECHNOLOGYDEVELOPMENTCO.,LTD.-CN105461618,2016,ALocationinpatent:Paragraph0051-0052
[4]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1Locationinpatent:Page/Pagecolumn19
[5]CurrentPatentAssignee:HETERODRUGSLIMITED-WO2016/71849,2016,A1Locationinpatent:Page/Pagecolumn21
[6]CurrentPatentAssignee:MSNLABORATORIESPRIVATELIMITED-WO2017/98522,2017,A1Locationinpatent:Page/Pagecolumn18;22;27;29
[7]CurrentPatentAssignee:ZYDUSLIFESCIENCESLTD-US2016/83345,2016,A1Locationinpatent:Paragraph0195
[1]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[2]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[3]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[4]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[5]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[6]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[1]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[2]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[3]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[4]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[1]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[2]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[3]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
[4]CurrentPatentAssignee:VIATRISINC-WO2016/12934,2016,A1
Title: Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study.
Journal: Lancet (London, England) 20130105
Title: Multiple functions of microsomal triglyceride transfer protein.
Journal: Nutrition & metabolism 20120101
Title: Mipomersen: evidence-based review of its potential in the treatment of homozygous and severe heterozygous familial hypercholesterolemia.
Journal: Core evidence 20120101
Title: New clinical perspectives of hypolipidemic drug therapy in severe hypercholesterolemia.
Journal: Current medicinal chemistry 20120101
Title: Familial hypercholesterolemia: present and future management.
Journal: Current cardiology reports 20111201
Title: Lomitapide.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions 20111001
Title: Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats.
Journal: Clinical and experimental pharmacology & physiology 20110501
Title: Lomitapide, a microsomal triglyceride transfer protein inhibitor for the treatment of hypercholesterolemia.
Journal: IDrugs : the investigational drugs journal 20100201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology 20090601
Title: Dyslipidemia and cardiovascular diseases.
Journal: Current opinion in lipidology 20090401
Title: Novel nonstatin strategies to lower low-density lipoprotein cholesterol.
Journal: Current atherosclerosis reports 20090101
Title: Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia.
Journal: Nature clinical practice. Cardiovascular medicine 20080801
Title: Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia.
Journal: The New England journal of medicine 20070111
Title: 5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP.
Journal: Bioorganic & medicinal chemistry letters 20041018
Title: Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor.
Journal: European journal of pharmacology 20021129
Title: A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors.
Journal: Journal of medicinal chemistry 20010315
Title: Sulsky R, et al. 5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP. Bioorg Med Chem Lett. 2004 Oct 18;14(20):5067-70.
Title: Davis KA. et al. Lomitapide: A novel agent for the treatment of homozygous familial hypercholesterolemia. Am J Health Syst Pharm. 2014 Jun 15;71(12):1001-8.
Title: Dhote V, et al. Inhibition of microsomal triglyceride transfer protein improves insulin sensitivity and reduces atherogenic risk in Zucker fatty rats. Clin Exp Pharmacol Physiol. 2011 May;38(5):338-44.
